IMU Biosciences
Last funding round
Raised
$14,500,000
Round
Series A
Investors
Led by Molten Ventures,LifeX Ventures
Startup details
IMU Biosciences is a techbio company revolutionizing immune powered precision medicine. They are coupling deep, systems-level immune profiling with a proprietary AI platform to build a detailed immune atlas for translational research and clinical practice.
www.imubiosciences.com
London, United Kingdom
Established in 2019
11-50 People
Healthcare, Healthcare IT
Founders
Founder Stories
Dr. Sterghois Moschos, PulmoBioMed
Recent 5 from Healthcare
Jul2024
1
3 weeks ago
London-based Beacon Therapeutics develops gene therapies for blinding retinal diseases.
Founders
David Fellows
In News
NewsnReleases
DirectorsTalk Interviews
2
3 weeks ago
Scotland-based MI:RNA Diagnostics specializes in early disease detection technology for animals using microRNA biomarkers.
Founders
Eve Hanks
In News
businessInsider
3
3 weeks ago
Colorado-based Hummingbird Healthcare streamlines patient access and operational efficiency for healthcare providers.
Founders
Jeremy Schwach
In News
Hitconsultant
4
3 weeks ago
Gurugram-based Amocare offers premium intimate wellness products with a focus on natural solutions.
Founders
Prabhat Maheshwari
In News
Entrackr
5
3 weeks ago
New York-based K Health provides AI-driven chatbot for patients before consulting physicians.
Founders
Allon Bloch
In News
Yahoo Finance
Recent 5 from United Kingdom
Jul2024
1
3 weeks ago
UK-based Natcap provides nature data for assessing risks and opportunities in corporate reporting.
Founders
Kathy Willis
In News
Carbon Pulse
2
3 weeks ago
London-based Altrove develops sustainable alternatives to critical earth materials.
Founders
Thibaud Martin,
Dr. Joonatan Laulainen
In News
Tech.eu
Tech Funding News
Yahoo Tech
StartupNews.fyi
3
3 weeks ago
UK-based TaperedPlus specializes in tech-enabled architectural design services for flat and tapered roof projects.
Founders
Robert Vass,
Aman Chahal
In News
Business Up North
4
3 weeks ago
London-based Beacon Therapeutics develops gene therapies for blinding retinal diseases.
Founders
David Fellows
In News
NewsnReleases
DirectorsTalk Interviews
5
3 weeks ago
Europe-based Trever provides infrastructure for digital asset management to financial institutions.
Founders
Hans-Jürgen Griesbacher
In News
Tech.eu